Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
or

Immuron Ltd ADR (IMRN)

Immuron Ltd ADR (IMRN)
1.7300 +0.0577 (+3.45%) 11:51 ET [NASDAQ]
1.7200 x 6 1.9000 x 21
Realtime by (Cboe BZX)
1.7200 x 6 1.9000 x 21
Realtime - - (-) -
Quote Overview for Tue, Apr 22nd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
1.7300
Day High
1.7768
Open 1.7768
Previous Close 1.6723 1.6723
Volume 1,940 1,940
Avg Vol 22,807 22,807
Stochastic %K 36.23% 36.23%
Weighted Alpha -34.57 -34.57
5-Day Change -0.0910 (-5.00%) -0.0910 (-5.00%)
52-Week Range 1.6001 - 2.8700 1.6001 - 2.8700
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,763
  • Shares Outstanding, K 5,838
  • Annual Sales, $ 3,220 K
  • Annual Income, $ -4,550 K
  • EBIT $ 0 M
  • EBITDA $ -6 M
  • 60-Month Beta 1.16
  • Price/Sales 3.44
  • Price/Cash Flow N/A
  • Price/Book 1.64

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.6001 +8.12%
on 04/11/25
Period Open: 1.7800
2.1000 -17.62%
on 03/28/25
-0.0500 (-2.81%)
since 03/21/25
3-Month
1.6001 +8.12%
on 04/11/25
Period Open: 2.1600
2.3200 -25.43%
on 01/28/25
-0.4300 (-19.91%)
since 01/22/25
52-Week
1.6001 +8.12%
on 04/11/25
Period Open: 2.6015
2.8700 -39.72%
on 09/04/24
-0.8715 (-33.50%)
since 04/22/24

Most Recent Stories

More News
Winter 2024 Investor Summit Virtual: Q4 Presentations Now Available for On-Demand Viewing

NEW YORK, NY / ACCESSWIRE / December 3, 2024 / Investor Summit Group, committed to advancing the MicroCap and SmallCap investment community, announces that the November 21, 2024 Winter Investor Summit...

IMRN : 1.7300 (+3.45%)
ULY : 4.73 (+4.19%)
IMUX : 0.9975 (+0.85%)
NMTC : 0.5351 (-5.63%)
SNGX : 2.06 (-0.48%)
TMG.VN : 0.115 (unch)
BLGO : 0.2271 (-4.82%)
FET : 14.97 (+1.84%)
ACFN : 14.5000 (+1.40%)
NRBO : 2.36 (+0.43%)
TGCB : 0.0340 (+5.26%)
SOTK : 3.91 (+6.02%)
Immuron Limited CEO to Present at Small Cap Growth Virtual Investor Conference on December 5, 2024

Immuron Limited CEO Steven Lydeamore will present at the Small Cap Growth Virtual Investor Conference on December 5, 2024.Quiver AI SummaryImmuron Limited announced that CEO Steven Lydeamore will present...

IMRN : 1.7300 (+3.45%)
Immuron Limited Announces Participation in the LD Micro Main Event XVI

Presentation on Wednesday, October 4th at 11:00 PTMelbourne, Australia--(Newsfile Corp. - September 18, 2023) - Immuron Limited (NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical...

IMRN : 1.7300 (+3.45%)
Immuron Limited Announces Participation in the LD Micro Invitational XIII

Melbourne, Australia--(Newsfile Corp. - May 16, 2023) - Immuron Limited (ASX: IMC) (NASDAQ: IMRN) announced today that it will be presenting at the 13th Annual LD Micro Invitational at the Luxe Sunset...

IMRN : 1.7300 (+3.45%)
Global Alzheimer’s Disease Diagnostics & Therapeutics Market Expected to Reach $9.6 Billion by 2027

Palm Beach, FL – May 9, 2023 – FinancialNewsMedia.com News Commentary – Alzheimer’s disease (AD) is a progressive and neurodegenerative disorder that attacks the brain’s nerve cells or neurons,...

TRVN : 1.2700 (+0.40%)
IMRN : 1.7300 (+3.45%)
IMC.AX : 0.062 (-3.13%)
LLY : 823.03 (+0.61%)
ACOR : 0.6610 (-24.86%)
SILO : 1.1400 (+7.55%)
Global Alzheimer's Disease Diagnostics & Therapeutics Market Expected to Reach $9.6 Billion by 2027

/PRNewswire/ -- Alzheimer's disease (AD) is a progressive and neurodegenerative disorder that attacks the brain's nerve cells or neurons, which results in loss...

TRVN : 1.2700 (+0.40%)
IMRN : 1.7300 (+3.45%)
LLY : 823.03 (+0.61%)
ACOR : 0.6610 (-24.86%)
SILO : 1.1400 (+7.55%)
Immuron US DoD Naval Medical Research Center Receives feedback on IND Application for New Campylobacter ETEC Therapeutic

MELBOURNE, Australia, July 26, 2022 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on...

IMRN : 1.7300 (+3.45%)
IMC.AX : 0.062 (-3.13%)
Immuron North American Travelan® Sales up 494% and Global sales up 431%

Highlights: North American FY22 Travelan® sales increased by +494% to $0.6MGlobal sales increased by 431% to $0.9MAustralian FY22 sales increased by...

IMRN : 1.7300 (+3.45%)
IMC.AX : 0.062 (-3.13%)
Immuron Receives European Patent Notification on Drug Composition to Treat Clostridioides difficile Associated Disease

MELBOURNE, Australia, July 07, 2022 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on...

IMRN : 1.7300 (+3.45%)
IMC.AX : 0.062 (-3.13%)
Immuron US DoD Naval Medical Research Center Submits IND Application for New Campylobacter ETEC Therapeutic

Key Points US Naval Medical Research Centre (NMRC) submits IND application to the U.S. Food and Drug administration (FDA)Two human phase II clinical...

IMRN : 1.7300 (+3.45%)
IMC.AX : 0.062 (-3.13%)

Business Summary

Immuron Limited is a bio pharmaceutical Microbiome company. It focused on oral immunotherapy using polyclonal antibody products for humans. The company is involved in developing therapeutic products in NASH, ASH and other diseases mediated through gut disbiosis. Immuron Limited is based in Armadale,...

See More

Key Turning Points

3rd Resistance Point 2.1142
2nd Resistance Point 2.0129
1st Resistance Point 1.8426
Last Price 1.7300
1st Support Level 1.5710
2nd Support Level 1.4697
3rd Support Level 1.2994

See More

52-Week High 2.8700
Fibonacci 61.8% 2.3849
Fibonacci 50% 2.2350
Fibonacci 38.2% 2.0852
Last Price 1.7300
52-Week Low 1.6001

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro